16 September 2016 EMA/76550/2016 Press Office

Organisational matters CHMP meeting 12-15 September 2016

The main organisational topics addressed during the September meeting related to: •

Election of Pierre Demolis as Chair to the Oncology Working party.



Election of Karl Broich as Chair to the Central Nervous System Working Party.



Election of Anders Lignell as Chair to the Infectious Diseases Working Party.



Election of Anabel Cortés Blanco as Chair to the Radiopharmaceutical Drafting Group.



Information about proposed topics and agenda for Joint CHMP-PDCO Strategic Review & Learning Meeting to be held in Brussels, 19-21 October 2016 under the Slovakian Presidency of the Council of the European Union.



Information about the outcome of a review of experience with the Early Background Summaries. A survey amongst CAT/CHMP/PRAC assessors was conducted following the pilot starting at the end of 2014. The data collection and analysis was completed based on a total 121 responses for the 21 products in scope of the exercise.



Update on data gathering project, which started in March 2014 in order to gather evidence needed by the European Commission in drafting future legislative proposal on fees. The goal was to assemble evidence about the time spent on procedures at EMA and national competent authorities.



Information about the intention to start publication CHMP ORGAM meeting agendas and minutes from October 2016 onwards. In addition, the Annex to the CHMP meeting Plenary agenda and minutes will be made public. This would improve transparency of the CHMP meeting outcome. Furthermore the publication of 4 annexes under CHMP monthly highlights: “Opinions on annual reassessments, renewals of marketing authorisations and accelerated assessment procedures”, “Opinions on safety variations”, “Guidelines and concept papers adopted” and “Organisational matters” (current document) will be discontinued.



Appointment of 2 additional experts to the Pharmacogenomics Working Party: Giuseppe Novelli and Ronald van Schaick.



Appointment of new member Jasenka Mršić Pelčić to replace Blaženka Jurišić (HR) to the Safety Working Party.

30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website www.ema.europa.eu/contact

An agency of the European Union

© European Medicines Agency, 2016. Reproduction is authorised provided the source is acknowledged.



Appointment of Greg Markey as a member to the Guideline Consistency Group replacing Pierre Demolis.



Nomination of Christian Schneider as observer to the Biosimilar Medicinal Product Working Party.



Nomination of Uta Buckpesch-Heberer (DE) and Giancarlo Zito (IT) as observers to the Central Nervous System Working Party.



Nomination of Yolanda Barbachano (UK) as observer to the Biostatistics Working Party.

Organisational matters EMA/76550/2016

Page 2/2

Organisational matters September 2016 - European Medicines Agency

Sep 16, 2016 - Election of Pierre Demolis as Chair to the Oncology Working party. •. Election of Karl Broich as Chair to the Central Nervous System Working ...

79KB Sizes 7 Downloads 55 Views

Recommend Documents

Organisational matters June 2016 - European Medicines Agency
Jun 24, 2016 - Send a question via our website www.ema.europa.eu/contact ... The main organisational topics addressed during the June meeting related to:.

September 2017 - European Medicines Agency - Europa EU
Oct 13, 2017 - applications for initial evaluations, extensions, variations and renewals concerning marketing authorisations (MAs); ... Initial evaluation of marketing authorisation applications. 2014. 2015. 2016 .... Out of scope. 1 Establishment of

July 2016 - European Medicines Agency - Europa EU
Jul 11, 2016 - EMA/COMP/451206/2016 ... Cannabidiol for treatment of graft-versus-host disease, Richardson Associates Regulatory ..... Best Regulatory.

October 2016 - European Medicines Agency - Europa EU
Nov 15, 2016 - Information Management Division ... This document provides current information related to the volume and evaluation of .... Plasma master file.

July 2016 - European Medicines Agency - Europa EU
Information is selected based on recommendations from consulted patients, consumers ... need one of the following: a modern web browser; a web-based news reader or a ..... person developing the medicine must submit an application to the.

monthly figures - December 2016 - European Medicines Agency
Jan 10, 2017 - Monthly statistics report: December 2016. EMA/18823/2017. Page 2/5. Table 1. Pre-authorisation: Marketing-authorisation applications*. 2013.

Veterinary pharmacovigilance 2016 - European Medicines Agency
Feb 16, 2017 - monitoring of several centrally authorised products ..... regulatory tools within the EU that are ... Following to this, a Rapid alert was circulated.

July 2016 - European Medicines Agency - Europa EU
Jul 4, 2016 - Send a question via our website www.ema.europa.eu/contact ... non-proprietary names (INN) and therapeutic areas for all new ... also available in the monthly reports of the Committee for Orphan Medicinal Products (COMP).

July 2016 - European Medicines Agency - Europa EU
For a list of RSS readers please refer to our RSS guide and follow the instructions ..... PCWP and HCPWP joint meeting: Workshop on social media - Sep 2016.

monthly figures - December 2016 - European Medicines Agency
Jan 10, 2017 - Applicants can request a re-examination. The first four rows present the outcome of the evaluation before a re-examination (or a.

May 2016 - European Medicines Agency - Europa EU
Jun 22, 2016 - Information Management Division ... This document provides current information related to the volume and evaluation of .... Plasma master file.

Report - European Medicines Agency
May 30, 2017 - Pharmaceutical companies are invited to present their pre-clinical data pertaining to ... patients per year, as many questions about the best use of ALK ... of knowledge and evidence to support the planning and regulatory.

PRAC Agenda 25-29 September 2017 - European Medicines Agency
Sep 25, 2017 - Send a question via our website www.ema.europa.eu/contact ...... 6.1.46. Naloxegol - MOVENTIG (CAP) - PSUSA/00010317/201703 .